LT - 1,3-Oksazolidino arba 1,3-oksazinano junginiai kaip oreksino receptoriaus antagonistai
EN - 1,3-OXAZOLIDINE OR 1,3-OXAZINANE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07D 413/14 |
(2006.01) |
|
|
A61K 31/4439 |
(2006.01) |
|
|
A61K 31/5355 |
(2006.01) |
|
|
A61P 1/04 |
(2006.01) |
|
|
A61P 1/14 |
(2006.01) |
|
|
A61P 3/00 |
(2006.01) |
|
|
A61P 9/12 |
(2006.01) |
|
|
A61P 25/06 |
(2006.01) |
|
|
A61P 25/08 |
(2006.01) |
|
|
A61P 25/14 |
(2006.01) |
|
|
A61P 25/16 |
(2006.01) |
|
|
A61P 25/18 |
(2006.01) |
|
|
A61P 25/20 |
(2006.01) |
|
|
A61P 25/22 |
(2006.01) |
|
|
A61P 25/24 |
(2006.01) |
|
|
A61P 25/28 |
(2006.01) |
|
|
A61P 25/36 |
(2006.01) |
|
|
A61P 29/00 |
(2006.01) |
|
|
A61P 37/02 |
(2006.01) |
European patent
| (11) |
Number of the document |
2862860 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
13804876.4 |
|
Date of filing the European patent application |
2013-06-13 |
| (97) |
Date of publication of the European application |
2015-04-22 |
| (45) |
Date of publication and mention of the grant of the patent |
2016-12-21
|
| (46) |
Date of publication of the claims translation |
2017-03-10
|
PCT application
| (86) |
Number |
PCT/JP2013/066322 |
|
Date |
2013-06-13 |
PCT application publication
| (87) |
Number |
WO 2013/187467 |
|
Date |
2013-12-19 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
2012135277 |
2012-06-15
|
JP |
Inventors
| (72) |
FUTAMURA Aya, JP
ARAKI Yuko, JP
ABE Masahito, JP
OHTA Hiroshi, JP
SUZUKI Ryo, JP
NOZAWA Dai, JP
|
Grantee
| (73) |
Taisho Pharmaceutical Co., Ltd.,
24-1, Takada 3-chome Toshima-ku, Tokyo 170-8633,
JP
|
Attorney or representative
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
Title
| (54) |
1,3-Oksazolidino arba 1,3-oksazinano junginiai kaip oreksino receptoriaus antagonistai |
| |
1,3-OXAZOLIDINE OR 1,3-OXAZINANE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-05-23 |
13 |
289.00
EUR
|
Next renewal fee
|
2026-06-13 |
